Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases

Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases

Brain metastases are an increasing burden among breast cancer patients, particularly for those with HER2+ and triple negative (TN) subtypes. Mechanistic insight into the pathophysiology of brain metastases and preclinical validation of therapies has relied almost exclusively on intracardiac injectio...

Descrición completa

Detalles Bibliográficos
Main Authors: María J. Contreras-Zárate, D. Ryan Ormond, Austin E. Gillen, Colton Hanna, Nicole L. Day, Natalie J. Serkova, Britta M. Jacobsen, Susan M. Edgerton, Ann D. Thor, Virginia F. Borges, Kevin O. Lillehei, Michael W. Graner, Peter Kabos, Diana M. Cittelly
Formato: Artigo
Idioma:English
Publicado: Frontiers Media S.A. 2017-11-01
Series:Frontiers in Oncology
Subjects:
patient-derived xenograft
brain metastases models
breast cancer
brain colonization
triple negative
HER2+
Acceso en liña:http://journal.frontiersin.org/article/10.3389/fonc.2017.00252/full

Internet

http://journal.frontiersin.org/article/10.3389/fonc.2017.00252/full

Títulos similares